^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
EarlyCDT®-Lung

Company:
Freenome
Type:
CE Marked

Details

Evidence
EarlyCDT-Lung is an extensively validated blood test that measures the levels of seven autoantibodies to lung cancer-associated antigens 4 years or more before diagnosis. It can detect all types of lung cancer at all stages of disease (I-IV) early with high accuracy. It can be used in conjunction with low dose CT scans (LDCT) to ‘rule-in’ lung cancer in patients with indeterminate pulmonary nodules (IPNs).
Cancer:
Lung Cancer
Gene:
CTAG1B (Cancer/testis antigen 1B), ELAVL4 (ELAV Like RNA Binding Protein 4), MAGEA4 (Melanoma antigen family A, 4), TP53 (Tumor protein P53)
Approvals
Date
Cancer
Gene
Drug
By
07/15/16
CE
Confirmatory trial(s)